All oligonucleotides used in this study were purchased from Integrated DNA Technologies (Coralville, IA) and are listed in Table S1 . We used a QuikChange II XL site-directed mutagenesis kit (Stratagene) to introduce amber stop codon (TAG), Y104D and Y104F substitutions at the Y104 position of pET15b-6HIS-RAD52 template plasmid using pairs of Y104TAG-F/R, Y104D-F/R and Y104F-F/R primers. Successful construction of the pET15b-6HIS-RAD52 Y104TAG(amber stop codon) , pET15b-6HIS-RAD52 Y104D and pET15b-6HIS-RAD52 Y104F plasmids was confirmed by sequencing (DNA Core Sequencing Facility, UIUC). RAD52, RAD52 Y104F , RAD52 Y104D and RPA were expressed and purified as previously described (Grimme et al, 2010). RAD52 Y104pCMF was expressed in E. coli BL21-Codon Plus RIL (Stratagene) harbouring pET15b-6HIS-RAD52 Y104TAG(amber stop codon) and pSUPT-UaaRS (encodes MjtRNA pCMF CUA FRET-based DNA Binding and Annealing Assays and MjTyrRS). The cells were grown at 37 °C in LB medium supplemented with 100 μg/ml ampicillin, 34 μg/ml chorolamphenicol.
efficiency (E FRET ). The calculated E FRET was plotted against protein concentrations using GraphPad Prism4 software. Where indicated, 2 nM RPA was pre-incubated with ssDNA for 3 minutes before the first addition of RAD52. Annealing of complementary oligonucleotides was monitored under similar conditions as the binding assays. The DNA substrates used were a T-28(Cy3) and complementary P-28(Cy5). Following the baseline (buffer and proteins) measurement, 0.5 nM of T-28(Cy3) was added to the reaction cuvette, and the signal was allowed to stabilize. Annealing was initiated by addition of the second half-reaction pre-incubated with 0.5 nM P-28(Cy5). Fluorescence of Cy3 and Cy5 was measured simultaneously at 0.1 s time resolution over the reaction time course (300 s). The averaged E FRET from 3 different experiments was plotted against time and fitted to a double exponential whose combined amplitude was compared to E FRET value for dsDNA (0.81) and ssDNA (0.18 as determined by mixing two heterologous and in the absence of protein) to determine the extent of annealing reaction. The initial rate of annealing was determined as the slope of the linear portion of the progress curve (5-20 s depending on the protein concentration) for each assay, divided by 0.63 (E FRET difference between fully single-stranded and fully annealed DNA) and multiplied by the total amount of dsDNA present (0.5 nM). Both the rate and extent of annealing were plotted against protein concentration and analyzed using GraphPad Prism4 software. ΦX174 dsDNA (DNA form I) linearized using XhoI endonuclease was used to examine the effect of dsDNA on ssDNA binding or annealing.
Cy3 Labelling of Amino Modified Oligonucleotide
The iAmMC6T-labeled oligonucleotides were reacted with Cy3 mono-NHS esters (GE Healthcare) according to the manufacturer's protocol. The reaction length of amino-modified DNA labelling with Cy3 monofunctional NHS esters was extended from 1 to 6 h. The labelled oligonucleotides were then purified using MicroSpin G-25 columns (GE Healthcare) followed by ethanol precipitation to remove unincorporated Cy3 NHS esters and dissolved into 10 mM Tris [pH 7.5] and 1mM EDTA. The labelling efficiency was determined spectrophotometrically by comparing the ratio of oligonucleotide (measured at 260 nm) and Cy3 dye (measured at 560 nm). Labelling efficiencies for oligonucleotides "22-(dT) 28 -Cy3-25" was 87.9%.
Preparation of ssDNA Oligonucleotide with Biotin, Cy3 and Cy5 Modifications
Since triple modification oligo DNA was not commercially available, phosphorylation, annealing, ligation and denaturing gel purification were applied to prepare biotin-30-Cy3-(dT) 28 -Cy5 ( Figure S4C -H). First, 15-Cy3-(dT) 28 -Cy5 was phosphorylated using T4 Polynucleotide Kinase (New England Biolabs). Then, Bio-15 and phosphorylated 15-Cy3-(dT) 28 -Cy5 were annealed with Scaf30. The annealed substrate was subjected to ligase reaction to fill the nick between Bio-15 and 15-Cy3-(dT) 28 -Cy5 using Rapid DNA Ligation Kit (Roche Applied Science). The conjugated biotin-30-Cy3-(dT) 28 -Cy5 oligonucleotide was electrophorased under TBE buffer using 15% (19:1 acrylamide and bis-acrylamide) and 8 M Urea denaturing PAGE gel. The target band of biotin-30-Cy3-(dT) 28 -Cy5 DNA was extracted from gel using Econospin column (EpochLifeScience) followed by ethanol precipitation and dissolved into 10 mM Tris [pH 7.5] and 1mM EDTA.
Cy3 Labelling of RAD52 and RAD52 Y104D
Fluorescent labelling of RAD52 and RAD52 Y104D proteins was performed by coupling Cy3 monoreactive NHS esters (GE Healthcare) to the primary amine group on the protein. Carrying out coupling reaction at pH 7.0 results in specific labelling of the N-terminal amino group of the polypeptide chain (Galletto et al., 2006) .
Briefly, samples were mixed with a 10-fold molar excess of the Cy3 monoreactive NHS esters (GE Healthcare) in buffer L (50 mM K 2 HPO 4 /KH 2 PO 4 , pH 7.0, 100 mM NaCl and 1 mM DTT) for 30 min at room temperature. Subsequently, the reaction mixtures were incubated for 12 h at 4 °C. The labelling reactions were terminated by addition of 50 mM Tris-HCl, pH 7.5. Cy3-labeled RAD52 and RAD52 Y104D were separated from the free dye using PD SpinTrap G-25 (GE healthcare). The ratio of dye incorporated per protein molecule was determined to be 0.82 mol Cy3 per monomer of RAD52 and 0.86 mol Cy3 per monomer of RAD52 Y104pCMF , utilizing ε 650 (Cy3) = 150,000 M -1 cm -1 and ε 280 (RAD52 or RAD52 Y104D ) = 40,740 M -1 cm -1 .
Preparation and detection of phosphorylated RAD52
Constitutively active v-ABL kinase (237-643 fragment derived from Abelson murine leukemia virus, New England Biolabs) was incubated with purified RAD52 or RAD52 Y104F in kinase buffer (50 mM Tris-HCl, pH 7.5, 10 mM MgCl 2 , 0.01% Brij35, 2 mM DTT and 0.2 mM ATP) for 30 min at 30 °C. Proteins were separated in 12.5% SDS-polyacrylamide gels and transblotted to PVDF membrane (BIO-RAD). Tyrosine phosphorylation was detected by Western blot analysis. Briefly, following incubation with the blocking buffer, the membrane was incubated with Anti-Phosphotyrosine 4G10 antibodies (Millipore), and then incubated with the secondary anti-mouse IgG conjugated to alkaline phosphatase (Sigma). ECF Substrate (GE Healthcare) was then added and allowed to incubate for approximately 5min. The membrane was rinsed and visualized using a Storm 840 PhosphorImager (GE Healthcare). Table S1 . Oligonucleotides used in the study Figure S3 . Presence of RPA has similar effect on the biphasic ssDNA binding mode of RAD52 and RAD52 Y104pCMF . We analyzed the effect of RPA on the wrapping of DNA by both unmodified RAD52 and RAD52 Y104pCMF . The assays were carried out essentially as those described in Figure 2E except that ssDNA (1 nM) was pre-incubated with 2 and 4 nM RPA prior to RAD52 addition. These amounts of RPA should be sufficient to saturate ssDNA considering the sub-nanomolar affinity of RPA for ssDNA (Gomes et al, 1996; Gomes & Wold, 1996; Kim et al, 1992) and its binding site size of 25-30 nucleotides (Kim et al, 1994) . The Figure S10 . In vitro phosphorylation effect of RAD52 on gapped DNA binding. To confirm that the effect elicited by pCMF incorporation is similar to actual phosphorylation, we carried out in vitro phosphorylation of RAD52 by a constitutively active v-ABL kinase fragment. (A) v-ABL kinase dependent phosphorylation of RAD52. RAD52 phosphorylation was analyzed by Western blot using Anti-Phosphotyrosine antibody as described in the supplementary methods. Although there are no reports in literature that v-ABL targets human RAD52, the peptide is similar to the catalytic core of c-ABL and somewhat promiscuously phosphorylates RAD52 in Y104 biased manner. (B) The changes in FRET population upon binding of RAD52, RAD52/v-ABL mixture, RAD52 Y104pCMF and RAD52 Y104D on DNA are displayed as FRET histograms. In the FRET histogram of v-ABL/RAD52 interacting with gapped DNA, the fully wrapped state had lower representation than in the case of RAD52 Y104pCMF , but higher than that observed in the wild type. RAD52 Y104D showed different histogram pattern from other three cases. (C) Representative FRET trajectories from a single DNA molecule in the presence of v-ABL/RAD52. Although some of the
